elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34291281-43EFCCD7-509F-4D1C-B7A1-47EBF780967D
Q34291281-43EFCCD7-509F-4D1C-B7A1-47EBF780967D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34291281-43EFCCD7-509F-4D1C-B7A1-47EBF780967D
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib.
P2860
Q34291281-43EFCCD7-509F-4D1C-B7A1-47EBF780967D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34291281-43EFCCD7-509F-4D1C-B7A1-47EBF780967D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1838e8b2f0a77a9b39aa21f3b874c04eedb537e2
P2860
The evolution and impact of therapy in multiple myeloma.